Volociximab Recruiting Phase 2 Trials for Methamphetamine Intoxication (Disorder) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04715230Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose